Regeneron Pharmaceuticals, Inc.
(NASDAQ : REGN)

( )
REGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 6.89%160.030.0%$1347.19m
AMGNAmgen, Inc. -0.13%249.621.3%$691.62m
NVAXNovavax, Inc. 3.43%201.3480.0%$571.11m
SNSSSunesis Pharmaceuticals, Inc. -1.50%7.880.7%$550.84m
ILMNIllumina, Inc. -1.26%398.073.5%$515.02m
GILDGilead Sciences, Inc. 0.63%65.301.0%$465.35m
REGNRegeneron Pharmaceuticals, Inc. 0.86%481.162.7%$431.65m
VRTXVertex Pharmaceuticals, Inc. 0.55%217.131.9%$373.76m
ALXNAlexion Pharmaceuticals, Inc. 1.02%155.292.0%$316.00m
BIIBBiogen, Inc. -0.15%265.791.7%$265.53m
BNTXBioNTech SE 2.28%132.600.0%$236.33m
EXASEXACT Sciences Corp. -0.67%127.1418.4%$192.79m
NBIXNeurocrine Biosciences, Inc. 2.24%95.054.9%$177.79m
CRSPCRISPR Therapeutics AG 1.85%123.110.6%$176.91m
TWSTTwist Bioscience Corp. 0.87%142.030.0%$150.98m

Company Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.